Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    ALZHEIMER DISEASE 14
Show Display Options
RSS Create an RSS feed from your search for:
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Study Evaluating How Quickly And To What Extent The 14-Carbon-SAM-531 Is Absorbed/Converted/Eliminated In Male Subjects
Condition: Alzheimer Disease
Intervention: Drug: SAM-531
2 Recruiting Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study
Condition: Alzheimer's Disease Prevention
Intervention: Behavioral: Aerobic vs. Non-Aerobic exercise
3 Completed Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy Elderly
Condition: Alzheimer's Disease
Intervention: Other: Ketasyn
4 Terminated Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers
Condition: Alzheimer's Disease
Intervention: Drug: AZD3480
5 Completed A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293
Conditions: Healthy Volunteers;   Mass Balance Study
Intervention: Drug: AZD3293
6 Recruiting Effects of Brain Beta-Amyloid on Postoperative Cognition
Condition: Postoperative Cognitive Dysfunction
Interventions: Drug: Florbetapir F 18 (18F-AV-45);   Other: no intervention

Indicates status has not been verified in more than two years